Kelly R. Thornburg
Corporate Officer/Principal en CHIMERIC THERAPEUTICS LIMITED .
Cargos activos de Kelly R. Thornburg
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03/02/2022 | - |
Historial de carrera de Kelly R. Thornburg
Antiguos cargos conocidos de Kelly R. Thornburg.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
XBIOTECH INC. | Director de Operaciones | 08/06/2015 | 05/05/2017 |
KITE PHARMA INC | Corporate Officer/Principal | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
Formación de Kelly R. Thornburg.
Rockhurst University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Australia | 2 |
Operativa
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
XBIOTECH INC. | Health Technology |
AMGEN INC. | Health Technology |
CHIMERIC THERAPEUTICS LIMITED | Health Technology |
Empresas privadas | 1 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Kelly R. Thornburg
- Experiencia